Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion type Assertion NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_head.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion description "[The high plasma concentration of PAX, the L/S genotype of 5-HTTLPR, and comorbid physical illness might be associated with a poor response to the initial phase of pharmacotherapy of PD with PAX.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_provenance.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion evidence source_evidence_literature NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_provenance.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion SIO_000772 19259652 NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_provenance.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion wasDerivedFrom befree-20150227 NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_provenance.
- NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_assertion wasGeneratedBy ECO_0000203 NP699480.RAeqT87xziAayHGGFa7OQUKmPU1yn6IzrtMZ7JUyxMrOc130_provenance.